DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $425,723 | -8.9% | 30,236 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $467,146 | -57.5% | 30,236 | -54.9% | 0.01% | -60.0% |
| Q4 2022 | $1,098,425 | -44.4% | 67,018 | -37.2% | 0.02% | -49.0% |
| Q3 2022 | $1,974,000 | +141.3% | 106,689 | +27.5% | 0.05% | +157.9% |
| Q4 2021 | $818,000 | -73.8% | 83,663 | -8.9% | 0.02% | -77.9% |
| Q3 2021 | $3,121,000 | +1114.4% | 91,843 | +1208.9% | 0.09% | +975.0% |
| Q2 2021 | $257,000 | -59.8% | 7,017 | -77.0% | 0.01% | -91.4% |
| Q4 2018 | $639,000 | +31.5% | 30,454 | +142.6% | 0.09% | +93.8% |
| Q3 2018 | $486,000 | – | 12,552 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |